In four patients, longitudinal analysis of subsequent lesions highlighted an increase in mutations, like missense or splice variants in the PMS2, SMARCA4, ARID1A, AKT1, BMPR1A, and PTEN genes, suggesting tumor evolution. Here, PMS2 is linked to neoplasm.